What can we learn from negative results in clinical trials for proliferative vitreoretinopathy?

doi:10.18240/ijo.2022.09.01

Home > Archive>Volume 15, Issue 9, 2022 >1413-1415. DOI:10.18240/ijo.2022.09.01

What can we learn from negative results in clinical trials for proliferative vitreoretinopathy?
DOI:
                        10.18240/ijo.2022.09.01
                    
Author:
                        
                        
                    
Corresponding Author:Peter Wiedemann. Medical Faculty, Leipzig University, Leipzig 04103, Germany. P@prwiedemann.de
Affiliation:
Clc Number:
Fund Project:

Article

Figures

Metrics

Reference

Cited by

Materials

Comments

Abstract:

Reference

Cited by

Get Citation

Peter Wiedemann. What can we learn from negative results in clinical trials for proliferative vitreoretinopathy?. Int J Ophthalmol, 2022,15(9):1413-1415

Copy

Article Metrics

Abstract:
PDF:
HTML:
Cited by:

Publication History

Received:July 11,2022
Revised:July 20,2022
Adopted:
Online: September 01,2022
Published:

Home

Articles

Journal Info

For Authors

For Reviewers

Publication Policies

News and Events

RSS

Get Citation

Share

Article Metrics

Publication History